Syringaresinol Protects against Type 1 Diabetic Cardiomyopathy by Alleviating Inflammation Responses, Cardiac Fibrosis and Oxidative Stress

ConclusionThe results indicated that SYR could be a potential therapeutic agent for the treatment of diabetic cardiomyopathy by inhibiting inflammation, fibrosis and oxidative stress. The signaling pathway of Keap1/Nrf2 and TGF ‐β/Smad could be used as therapeutic targets for diabetic complications.This article is protected by copyright. All rights reserved

Source: Molecular Nutrition and Food Research - July 29, 2020 Category: Food Science Authors: Guangru Li, Lei Yang, Lifeng Feng, Jiu Yang, Yafei Li, Jiale An, Dihua Li, Yang Xu, Yang Gao, Jing Li, Jie Liu, Liang Yang, Zhi Qi Tags: Research Article Source Type: research